Business Context and Reporting Period
Company: Varex Imaging Corporation (VREX)
Filing Type: Form 8-K (Current Report)
Date of Report: September 26, 2019
Reporting Period: Events occurring on September 26, 2019, and effective October 8, 2019.
Key Financial Metrics and Debt
This filing does not report revenue, profit, cash flow, or operating margins. It focuses exclusively on debt structure and credit facility modifications.
- New Debt Authorization: Amendment allows a Netherlands subsidiary to obtain a loan of up to €8,000,000 outside the main Credit Agreement to fund new building construction.
- Revolving Credit Commitment Reduction: The Company permanently reduced its revolving credit commitment by $25,000,000, lowering the total commitment to $125,000,000 effective October 8, 2019.
- EBITDA Definition Change: Consolidated EBITDA definition modified to exclude up to $6,000,000 of specific non-recurring cash expenses.
Material Changes Versus Prior Period
The filing details specific amendments to the Credit Agreement dated May 1, 2017:
- Expansion of Borrowing Capacity: Added a specific provision for a €8,000,000 loan for the Netherlands subsidiary, which was not previously available under the standard Credit Agreement terms.
- Reduction of Facility Size: Decreased the total revolving credit facility from $150,000,000 to $125,000,000, resulting in reduced commitment fees.
- Financial Covenant Adjustments: Clarified timing and definitions of exclusions for Consolidated EBITDA calculations.
Guidance, Outlook, and Risks
Management Commentary: The Company is proceeding with construction of a new facility in the Netherlands, necessitating the specific loan authorization. The reduction in the revolving credit facility is intended to lower ongoing fees.
Risks and Contingencies: The filing notes that the description of the Amendment is qualified by reference to the full text of the agreement (Exhibit 10.1). No specific new risks or contingencies were disclosed beyond the standard obligations of the amended credit agreement.
Investor Verification Checklist
- Verify the full text of Amendment No. 4 to the Credit Agreement (Exhibit 10.1) to understand specific covenants and conditions attached to the €8,000,000 Netherlands loan.
- Confirm the exact impact of the $25,000,000 commitment reduction on the Company's liquidity position and future borrowing flexibility.
- Review the specific "non-recurring cash expenses" excluded from Consolidated EBITDA to assess the impact on financial covenant compliance.
- Monitor the progress of the Netherlands construction project to ensure the new loan is utilized as intended.